In the UK, the mortality rate for Parkinson's disease in men was projected to remain stable at 15.5 male deaths per 100,000 men from 2024 through 2028. This forecasted consistency indicates no significant annual percentage change expected over this period.

As of 2023, the analysis lacks explicit pre-2024 data for comparing variations. However, with the projected steady rate through 2028, the Compound Annual Growth Rate (CAGR) over the next five years is anticipated to be 0%, reflecting no anticipated growth or reduction in mortality rates.

Future trends to watch for include:

Advances in medical research and treatment options potentially lowering future mortality rates.
Demographic changes, such as aging populations, which might impact disease prevalence and mortality.
Public health initiatives aiming to improve early diagnosis and patient management, potentially affecting future projections.